🇺🇸 FDA
Patent

US 7144575

Methods for selectively stimulating proliferation of T cells

granted A61KA61K2039/505A61K40/11

Quick answer

US patent 7144575 (Methods for selectively stimulating proliferation of T cells) held by United States of America as represented by the Secretary of the Air Force expires Mon Nov 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Dec 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K2039/505, A61K40/11, A61K40/46, A61K48/00